News Archive

/News Archive/

Xeltis’ restorative technology at Biomaterials

2019-06-11T12:52:57+00:00April 3rd, 2019|Latest News|

Preclinical data on Xeltis’ restorative heart valves will illustrate supramolecular materials’ potential application in clinical practice at the Society for Biomaterials annual meeting on Thursday 4 April. Xeltis CTO Martijn Cox will present 2-year preclinical data outlining the capability [...]

Xeltis’ RestoreX™ in Cardiovascular Pathology

2019-06-11T12:55:58+00:00March 8th, 2019|Latest News|

Peer-reviewed journal Cardiovascular Pathology published positive one-year in-vivo data on Xeltis’ RestoreX™ technology platform in its latest issue. According to the paper, preclinical results of RestoreX™ pulmonary graft confirmed the potential of Xeltis’ restorative cardiovascular approach. The study showed that [...]

Xeltis’ new leadership functional to next phase

2019-06-11T12:58:38+00:00March 1st, 2019|Latest News|

Mohammed El-Kurdi, PhD, Vice President for Tissue Science, and Luc Verhees, Senior Vice President for Clinical, Pre-clinical and Medical Affairs, joined Acting CEO Eliane Schutte - Xeltis CDO since 2016 - and CTO and Co-founder Martijn Cox on Xeltis’ leadership [...]

Xeltis data shortlisted at EACTS Techno-College Innovation Award

2019-02-14T11:30:53+00:00October 19th, 2018|News|

An abstract on Xeltis clinical data has been shortlisted as one of five finalists at the EACTS Techno-College Innovation Award. Professor Tomasz Mroczek from the Children’s University Hospital, Krakow, Poland will present 1-year Xeltis data on the “First clinical experience [...]

Xeltis’ aortic valve one of highest peer-review oral abstracts at TCT

2019-02-14T11:33:48+00:00September 18th, 2018|News|

Initial in vivo experience on Xeltis’ restorative aortic valve will feature as one of the highest peer-reviewed oral abstracts of TCT 2018. Professor Christian Spaulding, Chief, Interventional Cardiology, European Hospital Georges Pompidou, Paris (F), will present long-term pre-clinical on Xeltis’ [...]

Load More Posts